Results 71 to 80 of about 18,251 (231)
Cost-Effectiveness of Alendronate in the Treatment of Osteoporosis in Denmark - An Economic Evaluation Based on the Fracture Intervention Trial [PDF]
Background: The Fracture Intervention Trial (FIT) showed that the bisphosphonate alendronate reduces the risk of fractures in women with low bone mass in the United States. Objective: To estimate the cost-effectiveness (cost per life-year gained and cost
Jönsson, Linus +2 more
core
Lead contamination in humans has been linked to several health risks, such as anemia, cardiovascular problems, renal failure, and irreversible neurological damage.
Raghunath Acharya (11153752) +3 more
core +1 more source
Relationship between vitamin D deficiency and early implant failure and osseointegration
Abstract Background This systematic review investigated the relationship between pre‐operative vitamin D levels and implant osseointegration and implant‐related outcomes. It also assessed studies involving vitamin D supplementation before implant placement.
Richard J. Miron +8 more
wiley +1 more source
Alendronate-Induced Esophagitis: Possible Pathogenic Role of Hypersensitivity to Alendronate
Upper gastrointestinal tract mucosal irritations, such as esophagitis, have been reported as rare adverse events due to a variety of aminobisphosphonates, including alendronate sodium, which have been widely used to treat osteoporosis. Although the pathogenesis of aminobisphosphonate-induced esophageal mucosal irritation has not been clearly understood,
Naniwa, Taio +6 more
openaire +3 more sources
Abstract Objective The aim of this systematic review and meta‐analysis was to evaluate the longitudinal temporal pattern of periodontal probing depth (PPD) reduction in intrabony periodontal defects following non‐surgical periodontal therapy (NSPT), both as a monotherapy and with adjunctive locally delivered pharmacological agents.
Luca Ramaglia +4 more
wiley +1 more source
We compared the initial efficacy of denosumab (Dmab) and zoledronate (ZOL) in treatment‐naive patients with osteoporosis. This cohort study, based on TriNetX data, evaluated the risks of fractures and mortality using Kaplan–Meier survival analyses, with hazard ratios (HRs) and 95% confidence intervals (CIs).
Ko‐Hsiu Lu +2 more
wiley +1 more source
Prevention of bone loss in paraplegics over 2 years with alendronate
To assess the effects of long-term treatment of bone loss with alendronate in a group of paraplegic men, 55 patients were evaluated in a prospective randomized controlled open label study that was 2 years in duration comparing alendronate and calcium ...
Guido A Zäch +15 more
core +1 more source
Objective To investigate the effects of intra⁃articular injection of alendronate on the mandibular condyle in ovariectomized rats. Methods Sixty female rats were randomly divided into five groups: ovariectomy with vehicle treat⁃ ment alone, early ...
ZHU Song⁃ song
doaj +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Adrien Boyard +12 more
wiley +1 more source
ABSTRACT Lysinuric protein intolerance (LPI) is a rare disorder of dibasic amino acid transport associated with secondary urea cycle defects and immune dysregulation. Pregnancy in LPI is seldom reported and presents significant management challenges.
Eamon P. McCarron +8 more
wiley +1 more source

